I was thinking this last night.
20x improvement is a massive improvement. Could some of the 20x sensitivity improvements be Anteo using 3DNA as well as Mix&Go.
One thing to remember is that BBI's new agreements seem only to develop 3DNA lateral flow products and POC( at this stage). They have no agreements in place to sell the products which has been indicated they have "agreed to negotiate further licenses to permit BBI to commercialise such products". They could still be 12-24 months away from any sales of 3DNA contained products.
Many questions and hopefully we will here something either way sooner rather than later.
BBI announce acquisition for Lateral Flow and POC, page-70
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $67.22M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 370325 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 31036 | 1 |
View Market Depth
| Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
| ADO (ASX) Chart |
Day chart unavailable